Healthcare and Medicine

Regenerative Stenting Osteoporotic Tender

🏛️ ROYAL COLLEGE OF SURGEONS IN IRELAND
📄 Tender ID: 503493840 📅 Published: 02 May 2024

📋 Tender Overview

Regenerative Stenting For Osteoporotic Vertebral Fracture Repair
Osteoporotic Vertebral Fractures (Ovfs) Are The Most Common Complication Of Osteoporosis. Current Treatment Involves Conventional Procedures That Inject Cement Into The Vertebrae To Stabilise The Spine And Relieve Pain. No Reparative Treatment Exists. Biomaterial-Based Treatments Have Had Very Limited Success Due To A Number Of Complex Challenges, Such As Providing Dual Therapeutic And Mechanical Functionalities To Meet Clinical Requirements. Building On A Wealth Of Experience In The Area Of Materials Processes, We Propose The Solution. Restore Will Initially Overcome The Problems With Traditional Biomaterials Approaches By Utilising Recent Advances In The Area Of Advanced Manufacturing And 3D-Printing To Engineer A Dual Component Biomaterial Platform, Comprising Of A 3D-Printed Biodegradable Stent And A Thermoresponsive Hydrogel, With Mechanical Properties And Bioactive Composition Tailored To Regenerate And Repair Osteoporotic Vertebral Bone. Following This, And Consolidating The Research In The Applicant’S Lab On Biomaterial-Mediated Delivery Of Therapeutics To Enhance Bone Formation And Inhibit Resorption, The Hydrogel Component Will Be Functionalised For The Controlled Delivery Of Antioxidant Lanthanides, To Combat Increased Oxidative Stress In The Osteoporotic Bone Microenvironment, And Modulate Impaired Bone Remodelling To Drive Bone Regeneration And Facilitate Repair. The Restore Technology Has Potential For Use In A Patient Specific Personalized Medicine Format As The 3D-Printing Process Utilised Allows For The Stents To Be Tailored To The Patient’S Individual Vertebra. The Hydrogel’S Therapeutic Load Can Also Be Adjusted And Offers A Potential Minimally Invasive Prophylactic Treatment For Adjacent Diseased Vertebrae That Do Not Yet Require Stenting - A First-Of-Its-Kind Prevention Strategy For Ovfs. The Proposed Restore Platform Is Thus A Paradigm Shifting Disruptive Technology That Will Revolutionise The Way Damaged Osteoporotic Vertebrae Are Treated.
Funded Under
European Research Council (Erc)
Total Cost
€ 2 039 473,00
Eu Contribution
€ 2 039 473,00
Coordinated By
Royal College Of Surgeons In Ireland
Ireland
Start Date
1 June 2024
End Date
31 May 2029

🔍 Key Information

📄
Tender Reference No.
503493840
📅
Publication Date
02 May 2024
💰
Estimated Value
N/A
🌐
Sector
Healthcare and Medicine
📅
Deadline
31 May 2029
📝
Notice Type
Projects
📍
Location
Ireland
📑
Contract Duration
5 Years 29 Days

📁 Documents & Downloads

View All Documents →
# Document Name Type Action
2
T503493840.html
HTML

🏷️ CPV

No CPV found

Need help with this bid?

Our bid experts can help you find, evaluate & win more tenders.

🎧 Talk to Bid Expert
🕒 Submission deadline
927
days remaining · 31 May 2029
🔔 Set Alert

🧭 Quick Facts

Authority ROYAL COLLEGE OF SURGEONS IN IRELAND
Country Ireland
State / UT N/A
Tender Type Project Information
Currency EUR
Similar Tenders
Loading similar tenders…